Abstract:OBJECTIVE:To evaluate the characteristics of daily glucose change, insulin sensitivity, and insulin release in polycystic ovary syndrome (PCOS) women with normal glucose tolerance. METHODS:Oral glucose tolerance test (OGTT) with 75 g glucose was conducted on 20 PCOS women with normal glucose tolerance and 20 age-matched healthy women with normal menstruation. Before the glucose uptake and 30, 60, and 120 min after samples of venous blood were collected to detect the blood glucose and insulin. Continuous glucose monitoring system (CGMS) was used to monitor the glucose concentration of subcutaneous interstitial fluid so as to reflect the blood glucose level. Mean blood glucose level (MBG) and its standard deviation (SDBG), mean amplitude of glycemic excursion (MAGE), peak level of postprandial plasma glucose as well as its peaking time during a 48-hour period CGMS were calculated. Stumvoll first-phase and second-phase (1st PH and 2nd PH) insulin release during OGTT were evaluated by Stumvoll formula, whereas baseline insulin release by HOMA-B. Insulin sensitivity index (ISI) was evaluated by Cederholm formula. RESULTS:(1) The 1-hour and 3-hour plasma glucose levels during OGTT of the PCOS group were higher than those of the control group (P < 0.01 and P < 0.05 respectively). The fasting insulin level and insulin levels 30, 60, 120, and 180 min after the glucose uptake during OGTT of the PCOS group were all significantly higher than those of the control group (all P < 0.01). (2) The daily MBG, SDBG, and MAGE of the PCOS group were (5.43 +/- 0.44), (0.66 +/- 0.24), and (1.46 +/- 0.47) mmol/L respectively, all similar to those of the control group [(5.3 +/- 0.5), (0.67 +/- 0.27), and (1.7 +/- 0.7) mmol/L respectively, all P > 0.05]. The peaking time of post-breakfast plasma glucose level of the PCOS group was (40 +/- 18) min, significantly longer than that of the control group [(30 +/- 10) min, P < 0.05]. (3) The ISI of the PCOS group was 64 (59 - 81), significantly lower than that of the control group [95 (78 - 102), P < 0.01]. The Stumvoll 1st PH and 2nd PH insulin release levels of the PCOS group were 1779 (1411 - 2194) mU/L and 440 (361 - 545) mU/L respectively, both significantly higher than those of the control group [1217 (1056 - 1477) and 320 (283 - 375) mU/L respectively, P < 0.01 and P < 0.05]. CONCLUSION:With normal glucose tolerance, the PCOS women show (1) a backwardly-shifted peak of glucose -stimulated insulin secretion, (2) an abnormal mode of daily glucose change characterized by a delayed peak of post-breakfast plasma glucose level, and (3) significant decrease of peripheral insulin sensitivity with compensated increase of insulin secretion.

Predictive capability of fasting-state glucose and insulin measurements for abnormal glucose tolerance in women with polycystic ovary syndrome

Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome

Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance

To Assess the Association between Glucose Metabolism and Ectopic Lipid Content in Different Clinical Classifications of PCOS

[Insulin Release and Daily Glucose Change in Polycystic Ovary Syndrome Women with Normal Glucose Tolerance].

Evaluation of novel obesity- and lipid-related indices as predictors of abnormal glucose tolerance in Chinese women with polycystic ovary syndrome

Association of Serum Thyroid Hormone Levels with Androgen and Metabolic Parameters in Chinese Women with Polycystic Ovary Syndrome: A Retrospective Cross-Sectional Study

[Characteristics of Abnormal Glucose Tolerance in Patients with Polycystic Ovary Syndrome].

Relationship between hyperandrogen and impaired glucose regulation in women with polycystic ovary syndrome

Assessment Of Insulin Resistance In Chinese Pcos Patients With Normal Glucose Tolerance

Effect of HbA1C Detection on the Diagnostic Screening for Glucose Metabolic Disorders in Polycystic Ovary Syndrome.

Early Impaired Beta-Cell Function In Chinese Women With Polycystic Ovary Syndrome

Early impaired β-cell function in chinese women with polycystic ovary syndrome.

Prediction of Insulin Resistance and Impaired Fasting Glucose Based on Sex Hormone-Binding Globulin (SHBG) Levels in Polycystic Ovary Syndrome

SHBG Levels Do Not Correlate with Insulin Levels in PCOS with Appropriate Fasting Insulin Sensitivity

Association between the serum estrone-to-estradiol ratio and parameters related to glucose metabolism and insulin resistance in women with polycystic ovary syndrome

Continuous Glucose Monitoring Reveals Abnormal Features of Postprandial Glycemic Excursions in Women with Polycystic Ovarian Syndrome.

INSULIN RESISTANCE AND POLYCYSTIC OVARY SYNDROME IN A CHINESE POPULATION.

Metabolic Deregulations in Patients with Polycystic Ovary Syndrome

Association of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome

Gastrointestinal Hormone Secretion in Women with Polycystic Ovary Syndrome: an Observational Study